Merck cancer drug deal caps pharma investment influx into 'ADC' field
BioPharma
Stay updated with breaking news from Mablink Bioscience. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Ben Glickman Eli Lilly agreed to acquire preclinical biotechnology company Mablink Bioscience. Lyon, France-based Mablink, which develops antibody-drug...
Health-care companies declined as traders stepped back from makers of Covid 19 products. Pfizer tumbled to the lowest level since mid2020 as investors braced...
Health-care companies declined as traders stepped back from makers of Covid 19 products. Pfizer tumbled to the lowest level since mid2020 as investors braced for a pronounced slowdown in sales... -October 18, 2023 at 05:22 pm EDT - MarketScreener
By Ben Glickman Eli Lilly agreed to acquire preclinical biotechnology company Mablink Bioscience. Lyon, France-based Mablink, which develops antibody-drug conjugates, a new class of cancer...